Wyeth, Pfizer Face More Claims In Premarin Suit
Plantiffs in the multidistrict litigation alleging that Premarin and similar estrogen hormone-replacement drugs led to their breast cancer filed a motion Thursday to add further claims against Wyeth Inc. and Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article